Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.
Accelerate to discover
Related topics
InAlyzer to evaluate G6PD activity in relation with frailty
Mar 28, 2023
InAlyzer is body densitometry instrument for lab animals, equipped with 2 X-Ray sources and able to provide valuable...
Cardiomyocyte isolation using Cellenion’s cellenONE instrument
Mar 24, 2023
The cellenONE platform is ideal for the isolation of fragile and heterogeneous cell size populations, such as...
ACCELA educational webinar: Unlocking Spatial Biology with RareCyte Orion
Mar 16, 2023
Experience Spatial Biology with Orion Multiplex Imaging. Orion is a benchtop, high...
Recorded webinar: Anesthesia Considerations in Small Animal Imaging
Mar 13, 2023
Anesthesia settings and operation of Optical Imaging Systems: methods, animal handling, safety and regulatory...
Introducing Cytek Human Leukocyte Kit, the first ever 15-color lyse no-wash assay
Mar 13, 2023
This kit has been designed to enumerate all major leukocyte subsets and it mirrors and expands on those identified in a...
Immunofluorescence Imaging for Rare Cell Detection with CyteFinder II
Mar 7, 2023
CyteFinder II Instruments are high speed, whole slide imaging systems with options for liquid biopsy analysis and...
NanoCellect Webinar: Optimizing the Cell Line Development Process with Microfluidic Cell Sorting
Mar 3, 2023
Single-cell selection and cloning are required for bioengineering workflows such as antibody production, cell therapy,...
New Kit for Bacterial analysis expands capability of Guava Muse flow cytometer
Feb 20, 2023
With the Guava Muse cell analyzer, you can now achieve highly quantitative results at a fraction of the price, effort,...
Dec 12, 2016
Advances in multimodal preclinical imaging enable tracking of physiologic and structural changes together in vivo, for highly efficient longitudinal studies of disease progress and drug distribution, delivery and therapeutic response. Same-session X-ray, PET, SPECT, and/or optical views - automatically co-registered - provide detailed anatomic context for physiological metrics such as candidate biomarkers. Advanced software and techniques like spectral unmixing enable tracking of multiple measures together - for example, quantifying critical gene and protein expression, or co-locating a drug compound and its target.
Bruker's modular multimodal imaging systems let you choose which modalities to use with the option to add modalities as needed later, all within the same, small footprint. For highly detailed anatomic and functional studies, Bruker MRI and magnetic particle imaging systems provide outstanding spatial and time resolution, and complement clinical imaging methods for rapid translation of study results between animals and patients.
Learn more about preclinical imaging methods for drug discovery and development.
Related technologies: PET, SPECT, CT | Magnetic resonance imaging
Get more info
Brand profile
Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.
More info at:
www.bruker.com